Although, the clinical presentation of this patient is consistent with Bardet–Biedl Syndrome (BBS), given the vast number of loci associated with BBS (BBS1-BBS21) combined with the fact that no customized BBS targeted gene panel exists in Bangladesh, a decision was therefore taken to undertake WES. This evidence concerns the gene CFAP418 and Bardet-Biedl syndrome.